课题基金 / 基金详情

MECHANISMS OF EDEMA AND WEIGHT GAIN WITH PIOGLITAZONE

MECHANISMS OF EDEMA AND WEIGHT GAIN WITH PIOGLITAZONE
吡格列酮引起水肿和体重增加的机制
批准号：
7606526
负责人：
Robert Roy Henry
金额：
$3.49万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606526
关键词：
Body WeightComputer Retrieval of Information on Scientific Projects DatabaseEdemaFluid BalanceFundingGrantInstitutionPeripheralPioglitazoneResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthWeight Gaindiabeticglycemic control

项目摘要

项目成果

Robert Roy Henry的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 确定吡格列酮治疗对2型糖尿病患者体液平衡、外周水肿和体重的影响。确定吡格列酮治疗影响液体平衡、水肿和体重的机制，独立于血糖控制的影响
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the effects of pioglitazone therapy in type 2 diabetics on fluid balance, peripheral edema, and body weight. Determine the mechanisms by which pioglitazone treatment influences fluid balance, edema and body weight, independent of effects on glycemic control
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Epicatechin and derivatives to preserve muscle structure function in diabetes
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin